The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Medicis has no obligation to update any information contained in such press releases after the date of their issuance. For current information about the Company, please refer to our most recent public filings with the Securities and Exchange Commission.

Note that in November 2008 the Company restated its financial statements for the annual, transition and quarterly periods in fiscal years 2003 through 2007 and the first and second quarters of 2008, and, accordingly, filed an amended annual report on Form 10-K/A for the year ended December 31, 2007, and amended quarterly reports on Forms 10-Q/A for the quarters ended March 31, 2008, and June 30, 2008. Readers are cautioned to refer to the SEC filings associated with the Company's restatement for correct financial data.

Receive all Medicis press releases via email

View the Medicis Press Release Archive

2009 Press Releases
Keyword Search:  
Nov 9, 2009
Medicis to Present at Credit Suisse Annual Healthcare Conference
Nov 4, 2009
Medicis Reports Third Quarter 2009 Financial Results
Nov 2, 2009
Medicis Announces Third Quarter 2009 Conference Call and Webcast
Oct 13, 2009
Medicis Receives Notice of Allowance for SOLODYN(R) Patent
Sep 17, 2009
Medicis to Present At UBS Global Life Sciences Conference
Sep 16, 2009
Medicis Declares Cash Dividend
Sep 10, 2009
Medicis to Present At Morgan Stanley Global Healthcare Conference
Sep 8, 2009
Medicis to Present At Thomas Weisel Partners Healthcare Conference
Aug 5, 2009
Medicis Reports Second Quarter 2009 Financial Results
Jul 31, 2009
Medicis Announces Second Quarter 2009 Conference Call and Webcast
Jul 28, 2009
Medicis and Revance Announce Agreement for Development of Next-Gen Neurotoxin
Jul 27, 2009
Medicis Announces Approval of New Strengths of SOLODYN(R)
Jun 15, 2009
Health Canada Issues LIPOSONIX(TM) System Medical Device License
Jun 15, 2009
Medicis Begins Shipping Dysport(TM) for Glabellar Lines
Jun 12, 2009
Medicis to Present At Jefferies Healthcare Conference
Jun 10, 2009
Medicis Declares Cash Dividend
May 26, 2009
Medicis Announces New Patents for SOLODYN(R) 90mg
May 14, 2009
Medicis to Present At Deutsche Bank Health Care Conference
May 7, 2009
Medicis Reports First Quarter 2009 Financial Results
May 5, 2009
Medicis Announces First Quarter 2009 Conference Call and Webcast
Apr 30, 2009
FDA Approves DYSPORT(TM) for Therapeutic and Aesthetic Uses
Apr 17, 2009
Medicis Announces New Notice of Allowance for SOLODYN(R) 90mg
Apr 7, 2009
Medicis Announces Availability of Online Proxy Materials for 2009
Apr 3, 2009
Medicis Announces Notice of Allowance for SOLODYN(R) 90mg
Mar 18, 2009
Medicis and Teva Announce Settlement Agreement
Mar 12, 2009
Medicis to Present At Cowen & Company Conference
Mar 11, 2009
Medicis Declares Cash Dividend
Feb 25, 2009
Medicis Reports Fourth Quarter and Year-End 2008 Financial Results
Feb 23, 2009
Medicis Announces 2008 Fourth Quarter and Year-End Conference Call and Webcast
Feb 12, 2009
Medicis to Present At Roth Conference
Feb 10, 2009
Medicis to Present At Deutsche Bank Conference
Jan 8, 2009
Medicis to Present At JP Morgan Healthcare Conference

© 1996-2009 Medicis Pharmaceutical Corp